Missed the updated IDSA histoplasmosis guideline? This easy-to-read FAQ covers what clinicians caring for pregnant patients need to know.
|Videos|September 21, 2021
Vaccine campaign focuses on Hispanic population
Author(s)Angie DeRosa, Lindsey Carr, Editor
In this interview with Contemporary OB/GYN Senior Editor Angie DeRosa, Sergio Rimola, MD, discusses the Vaccinate4All campaign of the National Hispanic Medical Association (NHMA) and how ob-gyns can approach discussions with their LatinX patients.
Advertisement
Rimola is a practicing ob-gyn with Inova Health System in Vienna, Virginia, and co-chair of the NHMA for the Washington, D.C., metro area. The NHMA will be stepping up its efforts to get the Hispanic population vaccinated during National Hispanic Heritage Month, which will be held from September 15 to October 15.
Advertisement
Related to this article
The FDA accepted an sNDA and granted priority review for elinzanetant to treat VMS in women receiving endocrine therapy to treat or prevent HR+ breast cancer.
In the debut episode of Missed & Dismissed, Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, talks with Charis Chambers, MD, about PCOS, the push to rename it PMOS, and why diagnostic delays so often begin in adolescence.
Anita Nelson, MD, discusses the FDA's approval extending etonogestrel implant use to 5 years and the new REMS certification clinicians must complete by February 23, 2027.
Placentas from older mothers held less NAD+, and in aged pregnant mice, nicotinamide riboside or the CD38 inhibitor 78c restored placental NAD+ and improved fetal growth.
Hugh Taylor, MD, outlines a stepwise approach to endometriosis therapy, from first-line oral contraceptives to oral GnRH antagonists for progestin-resistant patients.
Hosted by Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, the monthly series brings clinicians, researchers, innovators, advocates, and other voices across women’s health into conversations that rarely happen in the same room.
A new book from Sameena Rahman, MD, reclaims "brown girls' disease" as a lens for examining how dismissal—of conditions, anatomy, and patients—undermines sexual medicine care for all women.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA grants priority review to elinzanetant for VMS in women receiving endocrine therapy for breast cancer
2
Q&A: Anita Nelson, MD, on etonogestrel implant's 5-year approval and REMS certification
3
Contemporary OB/GYN launches 'Missed & Dismissed' podcast to explore diagnostic gaps in women's health
4
Missed & Dismissed: The diagnostic gap starts in childhood
5